1. Home
  2. Labeler Index
  3. Cilag Ag
  4. 12502-5500
  5. NDC Package Code: 12502-5500-3 Rilpivirine Hydrochloride

NDC Package 12502-5500-3 Rilpivirine Hydrochloride

Injection, Suspension - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
12502-5500-3
Package Description:
16 VIAL in 1 TRAY / 44 VIAL in 1 VIAL / 3 mL in 1 VIAL
Product Code:
12502-5500
Non-Proprietary Name:
Rilpivirine Hydrochloride
Substance Name:
Rilpivirine Hydrochloride
11-Digit NDC Billing Format:
12502550003
Product Type:
Drug For Further Processing
Labeler Name:
Cilag Ag
Dosage Form:
Injection, Suspension - A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. It can also consist of an oil phase dispersed throughout an aqueous phase, or vice-versa.
Active Ingredient(s):
  • RILPIVIRINE HYDROCHLORIDE 200 mg/mL
    • Sample Package:
    N/A
    Marketing Category:
    DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
    Start Marketing Date:
    01-21-2021
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Unfinished Product:
    Yes
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    12502-5500-216 VIAL in 1 TRAY / 44 VIAL in 1 VIAL / 2 mL in 1 VIAL

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 12502-5500-3?

    The NDC Packaged Code 12502-5500-3 is assigned to an UNFINISHED drug package of 16 vial in 1 tray / 44 vial in 1 vial / 3 ml in 1 vial of Rilpivirine Hydrochloride, drug for further processing labeled by Cilag Ag. The product's dosage form is injection, suspension and is administered via form.

    Is NDC 12502-5500 included in the NDC Directory?

    Yes, Rilpivirine Hydrochloride is an UNFINISHED PRODUCT with code 12502-5500 that is active and included in the NDC Directory. The product was first marketed by Cilag Ag on January 21, 2021 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 12502-5500-3?

    The 11-digit format is 12502550003. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-112502-5500-35-4-212502-5500-03